Ste20-like kinases and regulator proteins in the cytoskeleton of Dictyostelium discoideum

The cytoskeleton in most eukaryotes consists of actin filaments, intermediate filaments, microtubules and specific associated proteins. It determines the shape and the polarity of a cell and is inevitable for the coordination of cell movement. The regulation of this complex structure requires a highly organised and specialised signalling network. Ste20-like kinases and the regulator protein Mo25 (Morula protein 25) are part of this signalling network. The main objective of this work was the functional characterisation of the regulator protein Mo25 and the Ste20-like kinases Fray1, Fray2 (Frayed kinase 1/2) and DstC (Dictyostelium serine threonine kinase C) in the amoeba Dictyostelium discoideum (D. discoideum). An additional project was to map and characterise the actin and actin related genes in the genome of the fresh water foraminifer Reticulomyxa filosa (R. filosa). Mo25 is a highly conserved 40 kDa scaffolding protein with a 60% identity from amoeba to man. The disruption of the mo25 gene in D. discoideum results in very large, multinucleated cells which are unable to complete cytokinesis. Growth as well as development is severely delayed in the Mo25-minus strain. Furthermore, in phototaxis assays performed with multicellular aggregates (slugs), the Mo25-minus slugs were unable to migrate towards the light source. These findings imply that Mo25 plays an important role in cytokinesis, growth and cell polarity. We could link the Ste 20-like kinase SvkA (severin kinase), a homolog of the human Mst3, Mst4 (Mammalian Ste20-like kinase 3/4) and Ysk1/Sok1 (Yeast Sps1/Ste20-related kinase 1, Suppressor of Kinase 1) kinases to Mo25 as a binding partner. To further elucidate the interaction of Mo25 with SvkA as well as their role in cytokinesis or polarity signalling, we generated a series of GFP–Mo25 rescue constructs with distinct point mutations in protein-protein interaction surfaces and transformed these into the Mo25-minus background. The kinase domains of the Ste20-like kinases, Fray1 and Fray2 in D. discoideum are highly homologous to the catalytic domains of OSR1 (Oxidative stress response kinase 1) and SPAK (Ste20/SPS1-related proline-alanine-rich protein kinase) in humans and Frayed in fruit fly. Here, we generated the knockout clones Fray1-minus, Fray2-minus, and the double knockout Fray2Fray1-minus in D. discoideum. In developmental studies, Fray2-minus did not show an altered phenotype, whereas Fray1-minus and Fray2Fray1-minus developed slightly slower into fruiting bodies. When grown in shaking culture, Fray1-minus and Fray2Fray1-minus showed a reduced growth rate compared to Fray2-minus and the wild type. In addition, by using a GFP-Trap resin we identified a binding partner of Fray1, a yet unknown protein that we named FRIP (Fray Interacting Protein). FRIP mainly consists of a CBS (Cystathionine beta synthase) domain pair and is 30% identical to the gamma subunit of the AMPK (5‘ adenosine mono phosphate-activated protein kinase) complex in D. discoideum. The Ste20-like kinase DstC has been described to be a regulator of the actin driven process of phagocytosis. The catalytic domain of DstC is most similar to the mammalian kinase Mst2 (Mammalian Ste20-like kinase 2) and Hippo (“Hippopotamus”-like phenotype) of D. melanogaster. We could map the sorting signal that localises DstC to phagocytic cups and acidic vesicles to about 90 amino acids. Here we present an array of distinct point mutations for the identification of the exact localisation signal. R. filosa is a fresh water protist which belongs to the the group of Foraminifera within the Rhizaria. The R. filosa genome is the first foraminiferal and only the second rhizarian genome to be deciphered. In this bioinformatics project, we could identify, map and characterise four new actin genes in addition to the already known actin and about 40 genes that code for potential actin related proteins of seven different protein classes.Das eukaryotische Zytoskelett besteht in der Regel aus Aktinfilamenten, Intermediärfilamenten, Mikrotubuli und spezifischen assoziierten Bindeproteinen. Es bestimmt Form und Polarität einer Zelle und ist damit maßgeblich an der Koordination der Zellbewegung beteiligt. Die Regulation dieser komplexen Vorgänge erfordert ein hoch spezialisiertes und organisiertes Signalsystem. Ein Teil dieses Signalsystems sind die Ste20-ähnlichen Kinasen und Mo25 (Morula protein 25), ein struktureller Organisator von Kinasen im Zytoskelett. Das Hauptziel dieser Arbeit war die funktionelle Charakterisierung des Proteins Mo25 und der Ste20-ähnlichen Kinasen Fray1, Fray2 (Frayed kinase 1/2) und DstC (Dictyostelium serine threonine kinase C) der sozialen Amöbe Dictyostelium discoideum (D. discoideum). Ein weiteres Projekt war die Kartierung und Charakterisierung der Aktine und Aktin verwandten Gene im Genom des Süßwasser Foraminiferen Reticulomyxa filosa (R. filosa). Das hoch konservierte, 40 kDa große Regulatorprotein Mo25 der Amöbe D. discoideum ist zu 60% identisch zu seinem Homolog im Menschen. Durch die Disruption des mo25-Gens in D. discoideum bilden sich sehr große, mehrkernige Zellen, welche sich nicht mehr normal teilen können. Das Wachstum, wie auch die Vollendung des Entwicklungszyklus sind in der Mo25-minus Mutante stark eingeschränkt. Ferner können sich die mehrzelligen Aggregate, die sogenannten „slugs“, in Phototaxis Experimenten nicht in Richtung einer Lichtquelle bewegen. Diese Ergebnisse weisen darauf hin, dass Mo25 eine wichtige Rolle bei Zellteilung, Wachstum und Zellpolarität spielt. Wir konnten die Ste20-ähnliche Kinase SvkA (Severin kinase), ein Homolog der menschlichen Kinasen Mst3, Mst4 (Mammalian Ste20-like kinase 3/4) und Ysk1/Sok1 (Yeast Sps1/Ste20-related kinase 1, Suppressor of Kinase 1), als einen Bindepartner von Mo25 verifizieren. Um die Wechselwirkung von Mo25 mit SvkA näher zu untersuchen, erzeugten wir eine Reihe von GFP-Mo25 Konstrukten mit verschiedenen Punktmutationen in den Protein-Protein Interaktionsflächen und brachten diese in die Mo25-minus Zelllinie ein. Daraufhin untersuchten wir die verschieden Auswirkungen der Punktmutationskonstrukte auf Zellteilung und Zellpolarität. Die Kinase-Domänen der Ste20-like-Kinasen, Fray1 und Fray2 der Amöbe D. discoideum weisen eine hohe Ähnlichkeit zu den katalytischen Domänen von OSR1 (Oxidative stress response kinase 1) und SPAK (Ste20/SPS1-related proline-alanine-rich protein kinase) im Menschen und zu Frayed in der Fruchtfliege Drosophila melanogaster (D. melanogaster) auf. Die Disruption der Gene fray1, fray2 einzeln und fray2 und fray1 zusammen ergab keine Veränderung im Phänotyp von D. discoideum. Auch der Entwicklungszyklus verlief im Vergleich zum Wildtyp nahezu unverändert. Lediglich beim Wachstum in Schüttelkultur zeigten die Fray1-minus und Fray2Fray1-minus Mutanten eine leicht verringerte Wachstumsrate im Vergleich zum Fray2-minus Stamm und dem Wildtyp. Zusätzlich konnte ein bisher unbekanntes Protein als Bindungspartner von Fray1 identifiziert werden, welches wir FRIP (Fray interacting protein) genannt haben. FRIP besteht hauptsächlich aus zwei CBS (Cystathionine beta synthase)-Domänen Paaren und ist zu 30% identisch zu der gamma-Untereinheit des AMPK (5‘ adenosine mono phosphate-activated protein kinase)-Komplexes in D. discoideum. Die Ste20-ähnliche Kinase DstC wurde als Regulatorprotein des Aktin-gesteuerten Prozesses der Phagozytose beschrieben. Die katalytische Domäne von DstC ist der homologen Domäne der Säugerkinase Mst2 (Mammalian Ste20-like kinase 2) und der Kinase Hippo (“Hippopotamus”-like phenotype) aus der Fruchtfliege sehr ähnlich. Wir konnten das Signal, welches DstC an den Zellmund und an angesäuerte Vesikel in D. discoideum lokalisiert, auf etwa 90 Aminosäuren eingrenzen. Hier präsentieren wir eine Zusammenstellung verschiedener Punktmutationen zur Veränderung der Aminosäuren, welche potentiell für die subzelluläre Lokalisierung des Proteins wichtig sind. R. filosa ist ein einzelliger Frischwasser Protist aus der Gruppe der Foraminiferen innerhalb der Rhizarien. Das R. filosa Genom ist das erste vollständig sequenzierte Genom der Foraminiferengruppe und erst das zweite der Rhizarien. In diesem bioinformatischen Projekt war es die Aufgabe, Aktin und Aktin-ähnliche Gene im Genom von R. filosa zu finden und zu kartieren

Role of High total protein in gallbladder bile in the formation of cholesterol gallstones.

While it is generally accepted that cholesterol supersaturation of bile is of key importance in the rapid formation of cholesterol crystals, the role of total biliary protein and pH in the pathogenesis of cholesterol gallstones is less well understood. The relation of cholesterol saturation, total protein, and pH was studied in 73 gallbladder bile samples with and 35 gallbladder bile samples without cholesterol crystals. In samples containing crystals, a trend to higher values of cholesterol and to a higher cholesterol saturation index was observed. However, significantly (P = 0.02) higher concentrations of total protein were found in samples with crystals [0.80 +/- 0.40 g/dL (8.0 +/- 4.0 g/L)] than in samples without crystals [0.63 +/- 0.26 g/dL (6.3 +/- 2.6 g/L)]. Moreover, of 22 bile samples with total protein concentrations greater than 10.0 g/L, cholesterol crystals were detected in all but 2. Total lipids, bile acids, phospholipids, and pH values were not significantly different in the two groups of bile samples. It was concluded that high biliary protein concentrations are frequently associated with cholesterol crystals and may, therefore, be a possible risk factor in the pathogenesis of cholesterol gallstones

The cytohesin paralog Sec7 of Dictyostelium discoideum is required for phagocytosis and cell motility

Background: Dictyostelium harbors several paralogous Sec7 genes that encode members of three subfamilies of the Sec7 superfamily of guanine nucleotide exchange factors. One of them is the cytohesin family represented by three members in D. discoideum, SecG, Sec7 and a further protein distinguished by several transmembrane domains. Cytohesins are characterized by a Sec7-PH tandem domain and have roles in cell adhesion and migration. Results: We study here Sec7. In vitro its PH domain bound preferentially to phosphatidylinositol 3,4-bisphosphate (PI(3,4) P-2), phosphatidylinositol 4,5-bisphosphate (PI(4,5)P-2) and phosphatidylinositol 3,4,5-trisphosphate (PI(3,4,5)P-3). When following the distribution of GFP-Sec7 in vivo we observed the protein in the cytosol and at the plasma membrane. Strikingly, when cells formed pseudopods, macropinosomes or phagosomes, GFP-Sec7 was conspicuously absent from areas of the plasma membrane which were involved in these processes. Mutant cells lacking Sec7 exhibited an impaired phagocytosis and showed significantly reduced speed and less persistence during migration. Cellular properties associated with mammalian cytohesins like cell-cell and cell-substratum adhesion were not altered. Proteins with roles in membrane trafficking and signal transduction have been identified as putative interaction partners consistent with the data obtained from mutant analysis. Conclusions: Sec7 is a cytosolic component and is associated with the plasma membrane in a pattern distinctly different from the accumulation of PI(3,4,5)P-3. Mutant analysis reveals that loss of the protein affects cellular processes that involve membrane flow and the actin cytoskeleton

BRAFΔβ3−αC^{Δβ3-αC} in-frame deletion mutants differ in their dimerization propensity, HSP90 dependence, and druggability

In-frame BRAF exon 12 deletions are increasingly identified in various tumor types. The resultant BRAF$^{Δβ3-αC}$ oncoproteins usually lack five amino acids in the β3-αC helix linker and sometimes contain de novo insertions. The dimerization status of BRAF$^{Δβ3-αC}$ oncoproteins, their precise pathomechanism, and their direct druggability by RAF inhibitors (RAFi) has been under debate. Here, we functionally characterize BRAF$^{ΔLNVTAP>F}$ and two novel mutants, BRAF$^{delinsFS}$ and BRAF$^{ΔLNVT>F}$, and compare them with other BRAF$^{Δβ3-αC}$ oncoproteins. We show that BRAF$^{Δβ3-αC}$ oncoproteins not only form stable homodimers and large multiprotein complexes but also require dimerization. Nevertheless, details matter as aromatic amino acids at the deletion junction of some BRAF$^{Δβ3-αC}$ oncoproteins, e.g., BRAF$^{ΔLNVTAP>F}$, increase their stability and dimerization propensity while conferring resistance to monomer-favoring RAFi such as dabrafenib or HSP 90/CDC37 inhibition. In contrast, dimer-favoring inhibitors such as naporafenib inhibit all BRAF$^{Δβ3-αC}$ mutants in cell lines and patient-derived organoids, suggesting that tumors driven by such oncoproteins are vulnerable to these compounds

Cancer risks by gene, age, and gender in 6350 carriers of pathogenic mismatch repair variants:findings from the Prospective Lynch Syndrome Database

Purpose Pathogenic variants affecting MLH1, MSH2, MSH6, and PMS2 cause Lynch syndrome and result in different but imprecisely known cancer risks. This study aimed to provide age and organ-specific cancer risks according to gene and gender and to determine survival after cancer. Methods We conducted an international, multicenter prospective observational study using independent test and validation cohorts of carriers of class 4 or class 5 variants. After validation the cohorts were merged providing 6350 participants and 51,646 follow-up years. Results There were 1808 prospectively observed cancers. Pathogenic MLH1 and MSH2 variants caused high penetrance dominant cancer syndromes sharing similar colorectal, endometrial, and ovarian cancer risks, but older MSH2 carriers had higher risk of cancers of the upper urinary tract, upper gastrointestinal tract, brain, and particularly prostate. Pathogenic MSH6 variants caused a sex-limited trait with high endometrial cancer risk but only modestly increased colorectal cancer risk in both genders. We did not demonstrate a significantly increased cancer risk in carriers of pathogenic PMS2 variants. Ten-year crude survival was over 80% following colon, endometrial, or ovarian cancer. Conclusion Management guidelines for Lynch syndrome may require revision in light of these different gene and gender-specific risks and the good prognosis for the most commonly associated cancers

Cancer risks by gene, age, and gender in 6350 carriers of pathogenic mismatch repair variants: findings from the Prospective Lynch Syndrome Database

*Shared first authorship (Dominguez-V M, Sampson J, Seppälä T)PURPOSE: Pathogenic variants affecting MLH1, MSH2, MSH6, and PMS2 cause Lynch syndrome and result in different but imprecisely known cancer risks. This study aimed to provide age and organ-specific cancer risks according to gene and gender and to determine survival after cancer. METHODS: We conducted an international, multicenter prospective observational study using independent test and validation cohorts of carriers of class 4 or class 5 variants. After validation the cohorts were merged providing 6350 participants and 51,646 follow-up years. RESULTS: There were 1808 prospectively observed cancers. Pathogenic MLH1 and MSH2 variants caused high penetrance dominant cancer syndromes sharing similar colorectal, endometrial, and ovarian cancer risks, but older MSH2 carriers had higher risk of cancers of the upper urinary tract, upper gastrointestinal tract, brain, and particularly prostate. Pathogenic MSH6 variants caused a sex-limited trait with high endometrial cancer risk but only modestly increased colorectal cancer risk in both genders. We did not demonstrate a significantly increased cancer risk in carriers of pathogenic PMS2 variants. Ten-year crude survival was over 80% following colon, endometrial, or ovarian cancer. CONCLUSION: Management guidelines for Lynch syndrome may require revision in light of these different gene and gender-specific risks and the good prognosis for the most commonly associated cancers.Peer reviewe

No Difference in Penetrance between Truncating and Missense/Aberrant Splicing Pathogenic Variants in MLH1 and MSH2: A Prospective Lynch Syndrome Database Study

Background. Lynch syndrome is the most common genetic predisposition for hereditary cancer. Carriers of pathogenic changes in mismatch repair (MMR) genes have an increased risk of developing colorectal (CRC), endometrial, ovarian, urinary tract, prostate, and other cancers, depending on which gene is malfunctioning. In Lynch syndrome, differences in cancer incidence (penetrance) according to the gene involved have led to the stratification of cancer surveillance. By contrast, any differences in penetrance determined by the type of pathogenic variant remain unknown. Objective. To determine cumulative incidences of cancer in carriers of truncating and missense or aberrant splicing pathogenic variants of the MLH1 and MSH2 genes. Methods. Carriers of pathogenic variants of MLH1 (path_MLH1) and MSH2 (path_MSH2) genes filed in the Prospective Lynch Syndrome Database (PLSD) were categorized as truncating or missense/aberrant splicing according to the InSiGHT criteria for pathogenicity. Results. Among 5199 carriers, 1045 had missense or aberrant splicing variants, and 3930 had truncating variants. Prospective observation years for the two groups were 8205 and 34,141 years, respectively, after which there were no significant differences in incidences for cancer overall or for colorectal cancer or endometrial cancers separately. Conclusion. Truncating and missense or aberrant splicing pathogenic variants were associated with similar average cumulative incidences of cancer in carriers of path MLH1 and path_MSH2

No Difference in Penetrance between Truncating and Missense/Aberrant Splicing Pathogenic Variants in MLH1 and MSH2: A Prospective Lynch Syndrome Database Study

Background. Lynch syndrome is the most common genetic predisposition for hereditary cancer. Carriers of pathogenic changes in mismatch repair (MMR) genes have an increased risk of developing colorectal (CRC), endometrial, ovarian, urinary tract, prostate, and other cancers, depending on which gene is malfunctioning. In Lynch syndrome, differences in cancer incidence (penetrance) according to the gene involved have led to the stratification of cancer surveillance. By contrast, any differences in penetrance determined by the type of pathogenic variant remain unknown. Objective. To determine cumulative incidences of cancer in carriers of truncating and missense or aberrant splicing pathogenic variants of the MLH1 and MSH2 genes. Methods. Carriers of pathogenic variants of MLH1 (path_MLH1) and MSH2 (path_MSH2) genes filed in the Prospective Lynch Syndrome Database (PLSD) were categorized as truncating or missense/aberrant splicing according to the InSiGHT criteria for pathogenicity. Results. Among 5199 carriers, 1045 had missense or aberrant splicing variants, and 3930 had truncating variants. Prospective observation years for the two groups were 8205 and 34,141 years, respectively, after which there were no significant differences in incidences for cancer overall or for colorectal cancer or endometrial cancers separately. Conclusion. Truncating and missense or aberrant splicing pathogenic variants were associated with similar average cumulative incidences of cancer in carriers of path MLH1 and path_MSH2

Risk-reducing hysterectomy and bilateral salpingo-oophorectomy in female heterozygotes of pathogenic mismatch repair variants : a Prospective Lynch Syndrome Database report

Purpose To determine impact of risk-reducing hysterectomy and bilateral salpingo-oophorectomy (BSO) on gynecological cancer incidence and death in heterozygotes of pathogenic MMR (path_MMR) variants. Methods The Prospective Lynch Syndrome Database was used to investigate the effects of gynecological risk-reducing surgery (RRS) at different ages. Results Risk-reducing hysterectomy at 25 years of age prevents endometrial cancer before 50 years in 15%, 18%, 13%, and 0% of path_MLH1, path_MSH2, path_MSH6, and path_PMS2 heterozygotes and death in 2%, 2%, 1%, and 0%, respectively. Risk-reducing BSO at 25 years of age prevents ovarian cancer before 50 years in 6%, 11%, 2%, and 0% and death in 1%, 2%, 0%, and 0%, respectively. Risk-reducing hysterectomy at 40 years prevents endometrial cancer by 50 years in 13%, 16%, 11%, and 0% and death in 1%, 2%, 1%, and 0%, respectively. BSO at 40 years prevents ovarian cancer before 50 years in 4%, 8%, 0%, and 0%, and death in 1%, 1%, 0%, and 0%, respectively. Conclusion Little benefit is gained by performing RRS before 40 years of age and premenopausal BSO in path_MSH6 and path_PMS2 heterozygotes has no measurable benefit for mortality. These findings may aid decision making for women with LS who are considering RRS.Peer reviewe